THE ACTION OF PHLORIZIN ON THE EXCRETION OF GLUCOSE, XYLOSE, SUCROSE, CREATININE AND UREA BY MAN.
作者信息
Chasis H, Jolliffe N, Smith H W
机构信息
Department of Physiology, New York University, New York City.
出版信息
J Clin Invest. 1933 Nov;12(6):1083-90. doi: 10.1172/JCI100559.
Abstract
摘要
相似文献
1
THE ACTION OF PHLORIZIN ON THE EXCRETION OF GLUCOSE, XYLOSE, SUCROSE, CREATININE AND UREA BY MAN.根皮苷对人体葡萄糖、木糖、蔗糖、肌酐和尿素排泄的作用。
J Clin Invest. 1933 Nov;12(6):1083-90. doi: 10.1172/JCI100559.
2
THE TRANSPORT OF UREA, CREATININE AND CERTAIN MONOSACCHARIDES BETWEEN BLOOD AND FLUID PERFUSING THE CEREBRAL VENTRICULAR SYSTEM OF RABBITS.尿素、肌酐及某些单糖在兔脑室系统灌注液与血液之间的转运
J Physiol. 1964 Jan;170(1):195-211. doi: 10.1113/jphysiol.1964.sp007323.
3
Metabolic adaptation to experimentally increased glucose demand in ruminants.
J Anim Sci. 1998 Nov;76(11):2938-46. doi: 10.2527/1998.76112938x.
4
Sugar interaction with the antiluminal surface of the proximal tubule in dog kidney.糖与犬肾近端小管抗腔面的相互作用。
Am J Physiol. 1977 May;232(5):F455-60. doi: 10.1152/ajprenal.1977.232.5.F455.
5
Competitive inhibition of SGLT2 by tofogliflozin or phlorizin induces urinary glucose excretion through extending splay in cynomolgus monkeys.托格列净或根皮苷通过延长伸展对映异构体抑制 SGLT2，从而诱导食蟹猴尿糖排泄。
Am J Physiol Renal Physiol. 2014 Jun 15;306(12):F1520-33. doi: 10.1152/ajprenal.00076.2014. Epub 2014 Apr 23.
6
New method of testing for carbohydrate absorption in man. Xylose and sucrose absorption; effects of sucrase inhibition.
Dig Dis Sci. 1986 Apr;31(4):369-75. doi: 10.1007/BF01311671.
7
Action of phlorizin on luminal and antiluminal membranes of proximal cells of kidney.
Am J Physiol. 1978 Jun;234(6):F485-9. doi: 10.1152/ajprenal.1978.234.6.F485.
8
Enzymatic synthesis of phlorizin fructosides.苯扎贝特葡萄糖苷的酶法合成。
Enzyme Microb Technol. 2021 Jun;147:109783. doi: 10.1016/j.enzmictec.2021.109783. Epub 2021 Mar 19.
9
Effects of phlorizin on glucose, water and sodium handling by the rat kidney.根皮苷对大鼠肾脏葡萄糖、水和钠处理的影响。
J Physiol. 1978 Feb;275:467-80. doi: 10.1113/jphysiol.1978.sp012201.
10
Species difference in mechanisms of D-xylose absorption by the small intestine.
Jpn J Physiol. 1984;34(4):669-77. doi: 10.2170/jjphysiol.34.669.
引用本文的文献
1
The Short and Sweet on Sodium-Glucose Cotransporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.心力衰竭中钠-葡萄糖协同转运蛋白抑制剂和胰高血糖素样肽-1受体激动剂的简要概述
US Cardiol. 2025 May 13;19:e12. doi: 10.15420/usc.2024.44. eCollection 2025.
2
Perioperative Considerations of Novel Antidiabetic Agents in Heart Failure Patients Undergoing Cardiac Surgery.接受心脏手术的心力衰竭患者围手术期新型抗糖尿病药物的考量
Life (Basel). 2025 Mar 8;15(3):427. doi: 10.3390/life15030427.
3
Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near.用于儿科肾脏疾病的钠-葡萄糖协同转运蛋白2抑制剂（SGLT2i）：未来已近在咫尺。
Front Pediatr. 2025 Jan 30;13:1521425. doi: 10.3389/fped.2025.1521425. eCollection 2025.
4
Medicinal Chemistry Strategies for the Modification of Bioactive Natural Products.药用化学策略在生物活性天然产物修饰中的应用。
Molecules. 2024 Feb 2;29(3):689. doi: 10.3390/molecules29030689.
5
Metabolic basis of solute carrier transporters in treatment of type 2 diabetes mellitus.溶质载体转运蛋白在2型糖尿病治疗中的代谢基础
Acta Pharm Sin B. 2024 Feb;14(2):437-454. doi: 10.1016/j.apsb.2023.09.004. Epub 2023 Sep 15.
6
Comparison of SGLT1, SGLT2, and Dual Inhibitor biological activity in treating Type 2 Diabetes Mellitus.SGLT1、SGLT2及双重抑制剂在治疗2型糖尿病中的生物学活性比较。
Adv Ther (Weinh). 2023 Dec;6(12). doi: 10.1002/adtp.202300143. Epub 2023 Sep 17.
7
A low-carbohydrate diet in place of SGLT2i therapy in a patient with diabetic cardiomyopathy.用低碳水化合物饮食替代糖尿病性心肌病患者的SGLT2i治疗。
Endocrinol Diabetes Metab Case Rep. 2023 Dec 13;2023(4). doi: 10.1530/EDM-23-0086. Print 2023 Oct 1.
8
SGLT inhibitors: a serendipitous glycaemic tale.
Nat Rev Endocrinol. 2024 Feb;20(2):65. doi: 10.1038/s41574-023-00923-3.
9
The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy.钠-葡萄糖协同转运蛋白2（SGLT-2）抑制剂在预防和治疗糖尿病心肌病中的重要性。
Antioxidants (Basel). 2022 Dec 19;11(12):2500. doi: 10.3390/antiox11122500.
10
Biomolecular Mechanisms of Cardiorenal Protection with Sodium-Glucose Co-Transporter 2 Inhibitors.钠-葡萄糖协同转运蛋白 2 抑制剂的心脏肾保护的生物分子机制。
Biomolecules. 2022 Sep 22;12(10):1349. doi: 10.3390/biom12101349.
Zotero 插件